after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

see chart post 655 and will reluctantly remind you all that i have recently posted that this company had little to commend it for investment and promptly got berated

cynic this is from your post 655
support probable at 1.45 on 200 dma ..... likely to be strengthened when 25 dma coincides

still don't like the share! ..... nothing to do with its risk profile
after the above post i cant find anyone that has berated you?

woodie your 678 is very cynic

lol

it happens so often that i may be mistaken on on this one, but i suspect not ..... am always being branded a deramper for failing to march with the herd ...... lol!
support or even bounce looks likely at 1.40 or when 50 dma hit which is much the same ..... so if you are a fan of this stock (not me) this may be an opportune moment

looks like i missed it all today lot's of if @ but look i keep telling you all the same thing forget for now this will go up and down look to the end of year or 2008 when
this go's internationally. in 2008 /2009 then you will all say i wish !!!! this is not what i'm saying this is all fact's.

micky...I don't think Ultrasis is a credible company at all.

Thanks cynic

98 ...............sorry but you must be joking wright........He is not alone. The 12,000 retail shareholders in Ultrasis could be forgiven for feeling downbeat. Dotcom investors pushed the shares to 73p valuing the company at almost 150m, but in fact Ultrasis was still testing its products and after posting annual losses of 2m and 5m, the shares slumped to less than 1p. The business moved down to Aim in May 2005. Now employs 17 people and generates sales of 1.2m.

Brabbins now believes the bad times for both Ultrasis and himself are in the past. In February last year the Beating the Blues programme was endorsed by the National Institute for Health and Clinical Excellence (Nice).

Although Ultrasis has yet to sign a definitive deal for a nationwide roll out of Beating the Blues, last week the Government gave further guidance on its intentions and it has committed to establish computer-aided programmes over the coming year........................this meens that they now have a programme so what could the company be worth now........

Less than 1p a share!

this is great got in again today hope it go's down abit more so i can buy more

micky ... you need to learn that falling knives are almost always very sharp ..... it is very bearish indeed (to my mind) that sp dropped straight through, and significantly so, a level that should have given some fairly serious support

Ultrasis PLC
23 April 2007


Press release 23 April 2007

Ultrasis plc

ICAS contract win for Beating the Blues


Ultrasis plc ('Ultrasis' or the 'Company'), the provider of computer-delivered,
interactive healthcare products and associated services, is to provide its
flagship programme Beating the Blues to ICAS, the leading employee assistance
provider, as an integral component of services offered by ICAS.

This is a new customer for Ultrasis, in a significant new market for the
Company, underlining the substantial market potential for Beating the Blues
beyond its current deployment, which is mainly in the public sector. The
agreement is further recognition of the benefits of using computers to deliver
access to treatments for common mental health problems such as depression and
anxiety.

ICAS is well established as one of the world's leading providers of work-based
psychological support. ICAS will actively support employees who access the
programme through its well established telephone counselling and remote case
management services.

Stephen Galliano, Chief Executive Officer of ICAS, said: 'We decided to add
Beating the Blues to our high-quality range of services after close consultation
with Ultrasis and a thorough evaluation of the programme. We expect BtB will
add greatly to our offering by enhancing employee performance, development and
well-being.

'With common mental health problems becoming a real concern in the workplace and
currently estimated to cost British business in excess of 9 billion per annum,
this is an ideal opportunity for our corporate customers to offer their
employees another way of accessing the latest, evidence-based treatments, either
to help support them to stay in work or, where absence is unavoidable, return to
work much sooner.'

Nigel Brabbins, Chief Executive of Ultrasis plc, said: 'We are delighted that
the partnership we are developing with ICAS will enable the employees whom they
support to get access to the latest, evidence-based treatments for depression
and anxiety.

'Importantly it will also help us to look at new models of delivery, using the
high-quality remote, case-management systems that ICAS has used to support
people for more than 20 years. What we learn from this could help inform new
ways to deliver healthcare in the future.'

morning woodie

it will all come good now hope this will be the 1 of many it a big big market out there for ULT and we have it all .............

morning micky lets hope so the s/price needs a lift

Fingers crossed we see many more, but I still see the NHS as the quantity stuff and the private contracts as the profitable ones.

agree alan

Interesting??http://www.pasa.nhs.uk/PASAWeb/Productsandservices/cCBT.htm

MICKY ..... looking back a few posts, i see i warned of trying to catch falling knives ..... not sure that you took heed ..... whether ULT has a decent product or not, it would seem to be dependent on NHS ..... as we all know, NHS is a total shambles and political football with no likelihood of it becoming remotely efficient in the foreseeable future ... that being so, what good reason is there to buy?

I agree with you, cynic. Anything that has a connection with NHS, the message is AVOID at all costs. It will go below 1p.

hi cynic
something i pick up

Many companies float in London with short-lived fanfare,
settling down to their work without further attention. Others
may have a good reputation for their main operations but have
quietly developed a sideline interest that could attract
widespread interest from the City, if only people knew about it.
Unless the house broker has been particularly active with
publishing research notes, such companies may struggle to get
on the radar of other analysts and thus the wider institutional
community. This situation can work to investors advantage, as
there is a good chance the stock will be cheap and its value
unrealised by the market makers. Naturally, there is the risk of
buying into a company that stays a hidden gem and doesnt get
the share price appreciation it deserves. Yet it is hard to keep a
good story quiet for too long, especially as more investment
houses are becoming interested in market niches to spot
tomorrows money maker.